GlassScriptPhysician profile
Richard H Bevan-Thomas
NPI 1982753158
$25,618.69
in general payments reported to CMS, 2019-2025
50 companies · $2,337 in 2025
The $2,337 reported for 2025 was more than what 83% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,693 · 2020: $3,221 · 2021: $1,133 · 2022: $1,248 · 2023: $4,374 · 2024: $9,614 · 2025: $2,337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,244 · Food and Beverage: $5,966 · Travel and Lodging: $3,999 · Grant: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,244.49 |
| Food and Beverage | $5,966.46 |
| Travel and Lodging | $3,999.25 |
| Grant | $113.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,168.79 | 2019-2025 | Da Vinci Surgical System |
| Boston Scientific Corporation | $2,552.99 | 2019-2025 | Greenlight Xps, Spaceoar Vue System - 10ml, Lithovue |
| Angiodynamics, INC. | $2,377.54 | 2023-2025 | Nanoknife |
| Bayer Healthcare Pharmaceuticals INC. | $2,077.48 | 2019-2022 | |
| Teleflex LLC | $1,957.62 | 2021-2025 | Urolift, Barrigel |
| Janssen Biotech, INC. | $1,295.86 | 2019-2025 | Erleada, Akeega |
| Neotract INC. | $1,285.31 | 2019-2020 | |
| Procept Biorobotics Corporation | $1,279.17 | 2024 | Aquabeam System |
| Healthtronics Stone Solutions, LLC | $586.49 | 2019-2021 | |
| Dendreon Pharmaceuticals LLC | $464.56 | 2019-2025 | Provenge |
| Palette Life Sciences, INC. | $431.22 | 2021-2023 | |
| Abbvie INC. | $406.62 | 2019-2025 | Lupron Depot, Botox |
| Sumitomo Pharma America, INC. | $376.54 | 2023-2025 | Orgovyx |
| Astellas Pharma US INC | $324.43 | 2019-2025 | Xtandi |
| Merck Sharp & Dohme LLC | $230.19 | 2021-2025 | Keytruda, Lynparza |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Bevan-Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.